Ethically questionable research with children: The Kennedy Krieger lead abatement study

Accountability in Research

Volumn 9, Issue 3-4, 2002, Pages 167-175

  Shamoo, Adil E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CHILD; ETHICS; GOVERNMENT REGULATION; HUMAN; HUMAN EXPERIMENT; LEAD POISONING; LEGAL ASPECT; PARENTAL CONSENT; SCIENTIFIC MISCONDUCT; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

BALTIMORE; CHILD; GOVERNMENT REGULATION; HUMANS; LEAD; LEAD POISONING; MARYLAND; NONTHERAPEUTIC HUMAN EXPERIMENTATION; PARENTAL CONSENT; SCIENTIFIC MISCONDUCT;

EID: 0038117628     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989620214684     Document Type: Article

References (26)

1. Adelman, S. A., Joseph, M. I., Stiller, S. D., Nilson, G. A., Reynolds, W. L., and Pasquier, E. W. (September 17, 2001). Appellee's Motion for Partial Reconsideration and Modification of Opinion.
2. Bor, J. (2001a). Lead paint lawsuits to go to trial, The Baltimore Sun, August 17, p. B1.
3. Bor, J. (2001b). Kennedy Krieger doctor defends lead paint study, The Baltimore Sun, August 18, p. B1.
4. Centers for Disease Control (CDC) (1991). Preventing Lead Poisoning in Young Children, Atlanta, GA.
5. Chao, J., and Kikano, G. E. (Jan., 1993). Lead poisoning in children, American Family Physician 47:113-120.
6. Curran, J. J., and Schwartz, J. (2001). Brief of the University of Maryland, Baltimore As Amicus Curiae in Support of Motion for Reconsideration, In Grimes v Kennedy Krieger Institute, Inc., September Term, 2000.
7. Farfel, M. R., and Chisolm, J. J. (1990), Health and Environmental Outcomes of Traditional and Modified Practices for Abatement of Residential Lead-Based Paint, Am. J. Public Health 80:1240-1245.
8. Food and Drug Administration (FDA) (1998). Regulation requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients: Final rule. Federal Register 63, 231:66631-66672.
9. 45 Code of Federal Regulation, Part 46.
10. Goldstein, G. W. (1992). Neurologic Concepts of Lead Poisoning in Children, Pediatric Annals 26:384-388.
11. Grimes v. Kennedy Krieger Institute, Inc., "Order" October, 2001, In The Court of Appeals of Maryland, Nos. 128 & 129, September Term, 2000. (Also, "On Motion for Reconsideration Per Curiam," October 11, 2001.)
12. Grimes v. Kennedy Krieger Institute, Inc., September Term 2000, No. 128 & 129, Motion of Aimic Curiae for Leave to file. Brief in support of Appellee's Motion for Reconsideration (2001).
13. Grimes, Erika v. Kennedy Krieger Institute, Inc., No. 128, September Term, 2000, Available on Maryland Judiciary. http://www.courts.state.md.us/opinions/coa/2001/128a00.pdf (Accessed 8/16/2001).
14. Kopelman, L. M. (2000). Children as Research Subjects: A Dilemma, J. Medicine and Philosophy 25:745-764.
15. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report, 1979. U.S. Department of Health, Education, and Welfare, Washington, D.C.
16. Nelson, R. M. (2001). Non-therapeutic Research, Minimal Risk, and the Kennedy Krieger Lead Abatement Study, IRB: Ethics and Human Research 23, No. 6: 7-11.
17. Pelton, T. (2001a). Kennedy Krieger sued over Lead Study, The Baltimore Sun, September 6, 2001, p. A1.
18. Pelton, T. (2001b). Lead paint rule could limit research in Md. Universities warn of lost of funds; lawyers say fear exaggerated; risk to children at issue. The Baltimore Sun, September 20, 2002.
19. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (National Commission), 1983, Summing Up (Washington, D.C.), U.S. Government Printing Office.
20. Roig-Franzia, M., and Weiss, R. (2001). Md Appeals Court Slams Researchers. The Washington Post, August 21, p. B1.
21. Shamoo, A. E., and Tauer, C. A. (2002). Ethically Questionable Research with Children: The Fenfluramine Study, Accountability in Research 9:143-166, 2002.
22. Shamoo, A. E., and Resnik, D. A. (2002). Responsible Conduct of Research. pp. 1-340, Oxford University Press.
23. st Century, J. F. Monagle and D. C. Thomasma, Editors, pp. 239-250, Gaithersburg, Maryland: Aspen Publishers.
24. Shamoo, A. E., and Keay, T. (1996). Ethical Concerns about Relapse Studies, Cambridge Quarterly of Health Care Ethics, 5:373-386.
25. Strong, K. W., Brief of Appellent and Joint Record Extract, Court of Special Appeals of Maryland, September Term 2000, No. 01600, Ericka Grimes v. Kennedy Krieger Institute, Inc.
26. Tauer, C. A. (1999). Testing Drugs in Pediatric Populations: The FDA Mandate, Accountability in Research 7: 37-58.